Na Sa

Also affiliated with Bristol-Myers Squibb (United States), Bristol-Myers Squibb (United Kingdom)

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Two Classes of Myosin Inhibitors, Para-nitroblebbistatin and Mavacamten, Stabilize β-Cardiac Myosin in Different Structural and Functional States”.

Two Classes of Myosin Inhibitors, Para-nitroblebbistatin and Mavacamten, Stabilize β-Cardiac Myosin in Different Structural and Functional States

Journal of Molecular Biology(2021)10.1016/j.jmb.2021.167295

N/A

0DataRank · unranked

49 citations

Weikang Ma, Srinivas Chakravarthy, Ariana C. Combs, Na Sa, Stephen J. Langer +3 more

Mechanisms of a novel regulatory light chain–dependent cardiac myosin inhibitor

The Journal of General Physiology(2024)10.1085/jgp.202313503

N/A

0DataRank · unranked

3 citations

Qing-Fen Gan, Ming Yu, Na Sa, Saffie Mohran, Yuanhua Cheng +11 more